- Previous Close
0.0000 - Open
0.1800 - Bid 0.1639 x --
- Ask 0.2439 x --
- Day's Range
0.1800 - 0.1800 - 52 Week Range
0.1500 - 0.1800 - Volume
3,488 - Avg. Volume
0 - Market Cap (intraday)
463.097M - Beta (5Y Monthly) 1.28
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 23, 2023
- 1y Target Est
--
Supermax Corporation Berhad, an investment holding company, manufactures, distributes, and markets medical gloves and contact lenses in Europe, North America, Central America, South America, Asia, Oceania, and Africa. It operates through four segments: Investment Holding, Manufacturing of Gloves, Trading of Gloves, and Others. The company offers various types of nitrile latex and natural rubber gloves, as well as personal protective equipment. It is also involved in the trading, importing, and distribution of latex gloves; generation of biomass energy; marketing and distribution of healthcare products and medical devices; and property holding activities. The company sells its products to laboratories, pharmacists, hospitals, doctors, and surgeons under the Supermax, Aurelia, and Maxter brands. It also exports its products to approximately 165 countries, including the United States, Europe, the Middle East, Asia, and the South Pacific countries. The company was founded in 1987 and is based in Sungai Buloh, Malaysia.
www.supermax.com.myRecent News: SPMXF
View MorePerformance Overview: SPMXF
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SPMXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SPMXF
View MoreValuation Measures
Market Cap
582.33M
Enterprise Value
375.38M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-26.64%
Return on Assets (ttm)
-1.81%
Return on Equity (ttm)
-4.58%
Revenue (ttm)
746.09M
Net Income Avi to Common (ttm)
-198.75M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.07B
Total Debt/Equity (mrq)
3.64%
Levered Free Cash Flow (ttm)
-378.14M